Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
First experience with a ready-for-use rheohemapheresis system
Autore:
Schreiner, T; Rink, S; Brunner, R; Borberg, H;
Indirizzi:
Deutsch Hamapherese Zentrum, D-50825 Cologne, Germany Deutsch Hamapherese Zentrum Cologne Germany D-50825 825 Cologne, Germany Univ Cologne, Klin & Poliklin Augenheilkunde, D-50924 Cologne, Germany Univ Cologne Cologne Germany D-50924 heilkunde, D-50924 Cologne, Germany
Titolo Testata:
TRANSFUSION AND APHERESIS SCIENCE
fascicolo: 2, volume: 24, anno: 2001,
pagine: 125 - 128
SICI:
1473-0502(200104)24:2<125:FEWARR>2.0.ZU;2-K
Fonte:
ISI
Lingua:
ENG
Soggetto:
FILTRATION; HELP;
Keywords:
differential filtration; rheohemapheresis; microcirculation; plasma viscosity; macular degeneration;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
11
Recensione:
Indirizzi per estratti:
Indirizzo: Schreiner, T Deutsch Hamapherese Zentrum, Maarweg 165, D-50825 Cologne, Germany Deutsch Hamapherese Zentrum Maarweg 165 Cologne Germany D-50825
Citazione:
T. Schreiner et al., "First experience with a ready-for-use rheohemapheresis system", TRANSF AP S, 24(2), 2001, pp. 125-128

Abstract

Rheohemapheresis is increasingly being used for the improvement of microcirculation in numerous diseases. The method is based on the constant-flow separation of plasma by a cell separator and the secondary filtration of plasma through a hollow-fiber membrane. A new CE-marked system has recently been launched for an improved continuous flow blood separator (dideco Excel Pro) that contains a connection kit between the cell separator and a secondary filter and software which includes differential filtration as a standard protocol. The new system was used in our center using ethylenevinylalcohol secondary filters (Evaflux LA4 or LA5).99 procedures were completed in 47 patients. A median of 2.7 (1.6-4.2) 1 of plasma were processed via the secondary filter in 109 (41-218) min. The values in peripheral blood before and after the treatment were total protein6.7 (5.8-8.9)/ 5.3 (4.4-6.7) g/dl, fibrinogen 215 (118-480)/110 (37-275) mg/dl and cholesterol 200 (134-254)/92 (69-149) mg/dl. A median platelet loss of 30% in the peripheral blood of the patients was observed partly by platelet content of the separated plasma of 30 g/l after 500 ml of treatment and 10 g/l after 2500 ml. Major side effects in the patients were not observed. The new differential filtration system already fulfills the demands of a ready-to-use CE-marked rheohemapheresis system but improvements in the details of the treatment protocol are still required and under way. (C) 2001 Elsevier Science Ltd. All rights reserved.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 06:47:55